Adult anti-syncytial vaccine protects for 3 seasons, says GSK

The farmaceutical group GSK has recently unveiled promising outcomes from its phase AReSVi-006 trial (Adult Respiratory Syncytial Virus). The study, which assessed the efficacy...

Rwanda: Confirmation of Marburg virus disease

On September 27, 2024, the Rwandan Ministry of Health (MOH) issued a statement confirming the occurrence of Marburg virus disease (MVD) in a number...

Mpox: Study shows virus immunity wanes within a year

A study conducted by researchers at Harvard Medical School and published in the medical journal JAMA revealed that immunity from the Mpox vaccine would...

Diphtheria outbreak in Guinea

According to the WHO Weekly Bulletin on Outbreak and other Emergencies (Week 40: 30 September to 6 October 2024), in light of the ongoing...

Ethiopia: Malaria outbreak update

According to the WHO Weekly Bulletin on Outbreak and other Emergencies (Week 40: 30 September to 6 October 2024), Ethiopia is confronting a considerable...

OSDIFE